[L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases]
- PMID: 888397
[L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases]
Abstract
Administration of 1-DOPA into healthy persons increased its excretion with urine and elevated the adrenaline secretion. The increase of catecholamines excretion was not observed in aged patients with hypertension; the data obtained suggest that the synthesis of catecholamines with utilization of DOPA was inhibited. In patients with ulcerous disease excretion of 1-DOPA was not increased after its administration, but secretion of catecholamines was decreased during the day time. Under ulcerous disease 1-DOPA appears to be used in process unrelated to synthesis of catecholamines.
Similar articles
-
[Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].Vopr Med Khim. 1980 Nov-Dec;26(6):782-6. Vopr Med Khim. 1980. PMID: 6779421 Russian.
-
[Catecholamine and DOPA excretion in peptic ulcer patients].Vopr Med Khim. 1973 Sep-Oct;19(5):518-23. Vopr Med Khim. 1973. PMID: 4788178 Russian. No abstract available.
-
[State of catecholamine and DOPA excretion in metabolic-alimentary obesity].Vopr Med Khim. 1974 May;20(3):257-65. Vopr Med Khim. 1974. PMID: 4836785 Russian. No abstract available.
-
[Reactivity of the DOPA--dopamine--noradrenaline--adrenaline system in epileptics].Zh Nevropatol Psikhiatr Im S S Korsakova. 1983;83(6):810-5. Zh Nevropatol Psikhiatr Im S S Korsakova. 1983. PMID: 6410626 Bulgarian.
-
[Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension].Kardiologiia. 1979 Oct;19(10):55-60. Kardiologiia. 1979. PMID: 502171 Russian.